1. Home
  2. RDIB vs INGN Comparison

RDIB vs INGN Comparison

Compare RDIB & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reading International Inc Class B

RDIB

Reading International Inc Class B

HOLD

Current Price

$9.01

Market Cap

204.7M

ML Signal

HOLD

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.55

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDIB
INGN
Founded
1937
2001
Country
United States
United States
Employees
2005
N/A
Industry
Movies/Entertainment
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.7M
177.1M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
RDIB
INGN
Price
$9.01
$6.55
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$11.25
AVG Volume (30 Days)
4.1K
221.8K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.42
EPS
N/A
N/A
Revenue
N/A
$348,668,000.00
Revenue This Year
$16.25
$8.03
Revenue Next Year
$4.04
$7.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.86
52 Week Low
$8.10
$5.34
52 Week High
$17.40
$9.13

Technical Indicators

Market Signals
Indicator
RDIB
INGN
Relative Strength Index (RSI) 47.36 50.51
Support Level $8.83 $6.00
Resistance Level $10.72 $6.72
Average True Range (ATR) 0.43 0.26
MACD 0.00 -0.01
Stochastic Oscillator 39.74 36.75

Price Performance

Historical Comparison
RDIB
INGN

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Share on Social Networks: